| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |